Pacira Pharmaceuticals Inc (PCRX) Financials

$25.36

$0.20 (0.79%)

As on 11-Sep-2026 16:00EDT

Market cap

$1,050 Mln

Revenue (TTM)

$746 Mln

P/E Ratio

75.3

P/B Ratio

1.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	746.16	726.41	700.97	674.98	666.82	541.53
Cost of Revenue	155.15	149.75	170.43	184.67	199.30	140.26
Gross Profit	591.01	576.66	530.54	490.31	467.53	401.28
Operating Expenses	572.57	543.36	603.91	402.63	407.50	311.35
Operating Profit (EBIT)	18.45	33.30	-73.37	87.68	60.02	89.92
Other Income	--	--	--	--	--	-1.77
Profit before Tax	17.65	16.87	-63.11	61.70	13.30	56.40
Provision for Tax	3.01	9.84	36.45	19.75	-2.61	14.42
Profit after Tax (Net Income)	14.64	7.03	-99.56	41.96	15.91	41.98
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	15.91	41.98

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	671.98	693.11	778.35	870.13	775.01	730.41
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	450.00	451.22	465.25	606.87	758.42	823.83
Current Liabilities	122.01	120.59	309.92	97.38	147.77	521.12
Total Liabilities	1,366.00	1,264.92	1,553.52	1,574.39	1,681.20	2,075.35

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	628.77	716.94	808.39	1,064.39	1,182.87	1,209.31
Current Assets	615.22	547.97	745.13	509.99	498.33	866.05
Total Assets	1,365.99	1,264.92	1,553.52	1,574.39	1,681.20	2,075.35
Total Debt*	412.12	454.38	638.85	586.04	763.39	1,128.85
Net Current Assets	493.20	427.38	435.21	412.61	350.56	344.93

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	151.99	189.39	154.65	145.27	125.72
Cash Flow from Investing Activities	--	99.48	-83.28	77.54	-225.19	-20.79
Cash from Financing Activities	--	-369.63	17.36	-183.03	-401.53	380.69
Net Cash Inflow / Outflow	--	--	--	--	--	485.62

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	0.35	0.16	-2.03	0.81	0.35	0.94
Cash EPS ($)	--	2.28	-0.42	2.49	2.34	1.25
Adjusted Book Value ($)	--	16.13	15.87	16.71	16.89	16.38
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	3.54	3.86	2.97	3.17	2.82
Free Cash Flow per Share ($)	--	3.18	3.65	2.68	2.51	1.79

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	0.55	-6.93	2.80	0.94	2.78
ROE (%)	2.14	0.96	-12.08	5.10	2.11	6.22
ROA (%)	0.91	0.50	-6.37	2.58	0.85	2.51
EBIT Margin (%)	3.97	4.33	-7.09	11.71	7.33	15.77
Net Margin (%)	1.96	0.97	-14.20	6.22	2.39	7.78
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	5.71	0.04	0.04	0.01	0.23	0.26
EBIT Growth (%)	132.42	163.38	-162.86	61.65	-42.77	95.85
Net Profit Growth (%)	111.48	107.07	-337.30	163.72	-62.10	-71.15
EPS Growth (%)	112.46	1.08	-3.52	1.32	-0.63	-0.71
Book Value Growth (%)	0.03	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	75.29	158.14	-9.28	41.87	111.35	63.92
Price / Book Value	1.58	1.60	1.19	2.02	2.29	3.67
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	10.52	10.84	37.02	13.35	16.00	27.69
Close Price ($)	25.37	25.88	18.84	33.74	38.61	60.17
High Price ($)	27.64	27.64	35.95	48.60	82.16	80.00
Low Price ($)	18.92	18.17	11.16	25.93	37.69	45.05
Market Cap ($ Cr)	1,050.36	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.54	0.66	0.82	0.67	0.99	1.55
Short term debt to equity ratio	0.02	0.01	0.27	0.02	0.06	0.52
Current Ratio	5.04	4.54	2.40	5.24	3.37	1.66
Quick Ratio	3.94	3.28	2.00	4.17	2.72	1.47
Interest Coverage	2.28	2.16	-3.00	4.56	1.37	2.95

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	17.75	17.08	16.16	15.64	14.76	17.79
Asset Turnover	0.46	0.52	0.45	0.41	0.36	0.32
Receivable days	--	59.68	57.02	55.18	53.33	50.37
Inventory Days	--	339.21	246.07	198.20	178.33	212.50
Payable days	--	41.81	37.32	30.58	23.61	27.31
Cash Conversion Cycle	--	357.08	265.77	222.80	208.05	235.56

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.